Key Points
- New therapies are being developed to effectively target diseases like cancer and diabetes.
- A partnership with Endo Axiom is advancing oral insulin delivery for Type 1 Diabetes.
- We focus on creating tailored solutions and ensure high standards in manufacturing for better patient care.
Recent breakthroughs are revolutionizing treatments for serious health issues such as cancer and diabetes. With innovations in bioconjugation and theranostics, researchers can now deliver medications with enhanced precision, minimizing side effects and improving effectiveness.
Bioconjugation is the technique of linking drugs to biological molecules. This allows us to design therapies that specifically target cancer cells or enable oral delivery of insulin, eliminating the need for painful injections. Theranostics expand this idea by combining diagnosis with treatment, meaning doctors can identify issues and immediately apply targeted therapies using the same agent.
Let’s take a closer look at bioconjugation.
The Basics of Bioconjugation
Bioconjugation involves chemically joining two or more molecules, with at least one being biological. This can help create treatments that deliver medications right where they are needed most. Often, researchers connect drugs or imaging agents to antibodies or other biological molecules to make therapies more targeted and effective.
For instance, scientists can attach a therapeutic drug to an antibody that specifically targets certain cells. This method significantly enhances treatment outcomes by delivering drugs only to desired locations.
Highlights: Quantum Dot Breakthrough
Our team proudly collaborated with Endo Axiom, spun out from the University of Sydney, to develop a new oral insulin delivery method that simplifies life for Type 1 Diabetes patients, especially children. This innovation can reduce the discomfort of daily injections and the risk of hypoglycemia.
Using quantum dot nanoparticles, which are tiny particles with unique properties, we enabled a delivery system that withstands the harsh conditions of the gut. This system allows insulin to be released in the small intestine, where it can then enter the bloodstream effectively.
Before moving into clinical trials, these nanoparticles undergo rigorous testing to ensure safety and efficacy. This research is crucial for a potential insulin alternative that could greatly improve the lives of diabetics.
Connecting Bioconjugation and Theranostics
Bioconjugates play a vital role in theranostics, which merges therapy and diagnostics. By employing biologically-linked agents, scientists can not only locate disease sites, like cancer, but also deliver targeted therapies effectively.
With a combination of a targeting antibody and a radioactive isotope, theranostic treatments enhance the precision and success rates of cancer treatments. The key benefits include better targeting of cancer cells and sparing healthy tissue from damage.
Targeting Ovarian Cancer
We also joined forces with Professor John Hooper from the University of Queensland and the Mater Research Institute to create a new antibody-drug conjugate focused on ovarian cancer. This conjugate can identify and treat cancer cells using a similar bioconjugation process.
This collaboration resulted in a regulated approach to ensure our therapy is ready for human trials while following stringent manufacturing standards.
The Path from Research to Manufacturing
Moving from research to actual manufacturing is crucial for any medical discovery. We are committed to bridging that gap with a reliable manufacturing process that meets industry standards. At our National Vaccine and Therapeutics Laboratory, we specialize in producing essential components for bioconjugated therapies, ensuring they are ready for clinical application.
By combining custom synthesis methods with large-scale production, we aim to lead the advancement of tailored medical therapies that have the potential to improve countless lives.
Source link
Bioconjugation, Theranostics, Targeted, therapies, personalised, personalized, medicine, cancer, treatment, diabetes, delivery, antibody, drug, drugs, conjugates, biomedical, manufacturing, biomanufacturing, research
